Abbott Laboratories
- ABT
- NYSE
- Medical devices
- Medical devices
- Diagnostics
- Nutrition Products
- Pharmaceuticals
$104.06
Today −0.79%Quote Oct 19, 2026, 07:59 PM UTC
+1.41%over the last month
Max drawdown −6.8%From 1-month high −0.8%3 months +4.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Abbott Laboratories
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Where the money comes from
Q2 2026 revenue $12.59B
- Medical Devices$5.85B46.5%
- Diagnostic Products$3.09B24.6%
- Nutritional Products$2.14B17.0%
- Established Pharmaceutical Products$1.50B11.9%
Sector
Healthcare
Industry
Medical devices
Exchange
NYSE
Employees
115,000
Founded
1888
Dividend date
Nov 16, 2026
Market value
$180.06B
Quote Oct 19
Floor
$103.93
0.1% below price
Resistance
$107.25
3.1% above price
Price vs analyst targets
42 analysts
Lowest target
$92.00Highest target
$134.00
$92.00Highest target
$134.00
- Price $104.06
- Average target $119.91
- Analysts' target range
Analysts' average target sits about 15% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ABTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free